FDA Sunscreen Decision Deadlines, Expedited TEAs Proposed
This article was originally published in The Tan Sheet
Executive Summary
The Sunscreen Innovation Act, introduced in both the House and the Senate, would streamline the process for FDA review of sunscreen TEAs and impose deadlines for agency action.
You may also be interested in...
Sunscreen TEA Review Deadlines In Limbo In House, Default Approvals Cut
The House Energy and Commerce Health subcommittee unanimously advances the Sunscreen Innovation Act to full committee, but provisions in the bill seeking a tight timeline for FDA’s review of sunscreen ingredient TEAs are in limbo, according to the Public Access to Sunscreens coalition of stakeholders.
Sunscreen TEA Review Deadlines In Limbo In House, Default Approvals Cut
The House Energy and Commerce Health subcommittee unanimously advances the Sunscreen Innovation Act to full committee, but provisions in the bill seeking a tight timeline for FDA’s review of sunscreen ingredient TEAs are in limbo, according to the Public Access to Sunscreens coalition of stakeholders.
EWG Seeks Realistic FDA Review Deadlines In Sunscreen Innovation Act
While the Environmental Working Group supports the Sunscreen Innovation Act, it would like to see realistic deadlines put in place to accelerate FDA’s review of sunscreen-ingredient time-and-extent applications without including a default mechanism that would grant free market access to certain sunscreen actives when FDA fails to act within allotted timeframes.